Compared with non-Hispanic White (NHW) children, non-Hispanic Black (NHB) and Hispanic/Latino (HL) children with a headache diagnosis in the emergency department have lower rates of migraine diagnosis ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

Older adults who engage in daily nut consumption have a significantly lower risk for death, dementia, and physical disability.

Children of women with epilepsy prescribed antiseizure medications do not have significant neurodevelopmental differences at age 6 years.

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Lifetime history of heavy cannabis use is associated with lower brain activation on working memory tasks among young adults.

Mental health disorders represent a significant problem in pediatric survivors of arterial ischemic stroke (AIS).

Occupational exposure to noise and/or vibrations is associated with the presence of vertigo, according to a study.

Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.